Temsirolimus Kit
Product Images NDC 72611-785

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Temsirolimus (NDC 72611-785). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Almaject, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Diluent-vial (Diluent Vial)

Label for Temsirolimus Injection diluent, specifying a 2.2 mL single-dose vial. The label indicates it is sterile, for dilution only, not for direct administration, and should be refrigerated. Contains 25.14% dehydrated alcohol by volume. Distributed by Almaject, Inc., Morristown, NJ, USA, manufactured in India. Includes lot and expiration placeholders, a barcode, and the NDC 72611-782-01.*

FDA Label Image

Figure-1 (Figure 1)

A Kaplan-Meier survival curve graph comparing overall survival between Temsirolimus 25 mg and Interferon treatments. The x-axis represents months to death from randomization, and the y-axis represents the survival distribution function, showing a declining survival over time for both groups with Temsirolimus having a higher survival curve than Interferon.*

FDA Label Image

Kit-carton (Kit Carton)

Packaging label for Temsirolimus Injection 25 mg/mL per vial, a sterile prescription drug kit by Almaject, Inc. The label shows it is for intravenous infusion only and concentrated, requiring dilution. Each carton contains one vial of Temsirolimus Injection and one vial of diluent. Manufactured by Gland Pharma Limited in India. The label includes storage instructions to refrigerate and protect from light, and details about vial contents and overfill.*

FDA Label Image

Structure (Structure)

Chemical structure of Temsirolimus Injection, showing the molecular arrangement of atoms and bonds in the active ingredient Temsirolimus.*

FDA Label Image

Temsirolimus-concentrate-vial (Temsirolimus Concentrate Vial)

Label for Temsirolimus Injection 25 mg/mL per vial by Almaject, Inc. This sterile, single-dose vial is for intravenous infusion only and must be diluted to 10 mg/mL after initial dilution. The kit contains dehydrated alcohol and sodium chloride for dilution and refrigeration is required. The label includes lot and expiration fields, a barcode, and manufacturer details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.